Search research articles
Contact Us
Filters
Showing results (101-110 of 117) with videos related to
Page
of 12
Sort By:
Oncogene
|
May 11, 2018
MASTL overexpression promotes chromosome instability and metastasis in breast cancer
Samuel Rogers, Rachael A McCloy, Benjamin L Parker, et al.
Cancers
|
October 13, 2021
Relationship between Circulating Lipids and Cytokines in Metastatic Castration-Resistant Prostate Cancer
Hui-Ming Lin, Nicole Yeung, Jordan F Hastings, et al.
Science (New York, N.Y.)
|
June 6, 2020
MTOR signaling orchestrates stress-induced mutagenesis, facilitating adaptive evolution in cancer
Arcadi Cipponi, David L Goode, Justin Bedo, et al.
Cell Reports
|
June 14, 2018
Intravital Imaging to Monitor Therapeutic Response in Moving Hypoxic Regions Resistant to PI3K Pathway Targeting in Pancreatic Cancer
James R W Conway, Sean C Warren, David Herrmann, et al.
The Journal of Experimental Medicine
|
March 21, 2023
Human PIK3R1 mutations disrupt lymphocyte differentiation to cause activated PI3Kδ syndrome 2
Tina Nguyen, Anthony Lau, Julia Bier, et al.
Nature Communications
|
August 6, 2022
Temporal profiling of the breast tumour microenvironment reveals collagen XII as a driver of metastasis
Michael Papanicolaou, Amelia L Parker, Michelle Yam, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 18, 2025
PSKH1 kinase activity is differentially modulated via allosteric binding of Ca<sup>2+</sup> sensor proteins
Christopher R Horne, Toby A Dite, Samuel N Young, et al.
Science Advances
|
March 3, 2023
Memory of stochastic single-cell apoptotic signaling promotes chemoresistance in neuroblastoma
Jordan F Hastings, Sharissa L Latham, Alvin Kamili, et al.
Nature Communications
|
August 14, 2019
CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan
Claire Vennin, Pauline Mélénec, Romain Rouet, et al.
Science Translational Medicine
|
July 27, 2018
Inhibition of activin signaling in lung adenocarcinoma increases the therapeutic index of platinum chemotherapy
Kieren D Marini, David R Croucher, Rachael A McCloy, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 117) with videos related to
Sort By:
Page
of 12
Oncogene
|
May 11, 2018
MASTL overexpression promotes chromosome instability and metastasis in breast cancer
Samuel Rogers, Rachael A McCloy, Benjamin L Parker, et al.
Cancers
|
October 13, 2021
Relationship between Circulating Lipids and Cytokines in Metastatic Castration-Resistant Prostate Cancer
Hui-Ming Lin, Nicole Yeung, Jordan F Hastings, et al.
Science (New York, N.Y.)
|
June 6, 2020
MTOR signaling orchestrates stress-induced mutagenesis, facilitating adaptive evolution in cancer
Arcadi Cipponi, David L Goode, Justin Bedo, et al.
Cell Reports
|
June 14, 2018
Intravital Imaging to Monitor Therapeutic Response in Moving Hypoxic Regions Resistant to PI3K Pathway Targeting in Pancreatic Cancer
James R W Conway, Sean C Warren, David Herrmann, et al.
The Journal of Experimental Medicine
|
March 21, 2023
Human PIK3R1 mutations disrupt lymphocyte differentiation to cause activated PI3Kδ syndrome 2
Tina Nguyen, Anthony Lau, Julia Bier, et al.
Nature Communications
|
August 6, 2022
Temporal profiling of the breast tumour microenvironment reveals collagen XII as a driver of metastasis
Michael Papanicolaou, Amelia L Parker, Michelle Yam, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 18, 2025
PSKH1 kinase activity is differentially modulated via allosteric binding of Ca<sup>2+</sup> sensor proteins
Christopher R Horne, Toby A Dite, Samuel N Young, et al.
Science Advances
|
March 3, 2023
Memory of stochastic single-cell apoptotic signaling promotes chemoresistance in neuroblastoma
Jordan F Hastings, Sharissa L Latham, Alvin Kamili, et al.
Nature Communications
|
August 14, 2019
CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan
Claire Vennin, Pauline Mélénec, Romain Rouet, et al.
Science Translational Medicine
|
July 27, 2018
Inhibition of activin signaling in lung adenocarcinoma increases the therapeutic index of platinum chemotherapy
Kieren D Marini, David R Croucher, Rachael A McCloy, et al.
Page
of 12